JP2006335694A5 - - Google Patents

Download PDF

Info

Publication number
JP2006335694A5
JP2006335694A5 JP2005163086A JP2005163086A JP2006335694A5 JP 2006335694 A5 JP2006335694 A5 JP 2006335694A5 JP 2005163086 A JP2005163086 A JP 2005163086A JP 2005163086 A JP2005163086 A JP 2005163086A JP 2006335694 A5 JP2006335694 A5 JP 2006335694A5
Authority
JP
Japan
Prior art keywords
osteoarthritis
molecular weight
low molecular
therapeutic agent
weight hyaluronan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005163086A
Other languages
English (en)
Other versions
JP2006335694A (ja
JP4041856B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005163086A priority Critical patent/JP4041856B2/ja
Priority claimed from JP2005163086A external-priority patent/JP4041856B2/ja
Publication of JP2006335694A publication Critical patent/JP2006335694A/ja
Publication of JP2006335694A5 publication Critical patent/JP2006335694A5/ja
Application granted granted Critical
Publication of JP4041856B2 publication Critical patent/JP4041856B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

  1. −Ｄ−グルクロン酸−β−１，３−Ｄ−Ｎ−アセチルグルコサミン−β−１，４−を１単位とし、これを１個〜１０個含む２糖〜２０糖の低分子量ヒアルロナンを有効成分とする変形性関節症治療剤。
  2. 上記低分子量ヒアルロナンのうち、１単位を２個含む４糖であることを特徴とする請求項１記載の変形性関節症治療剤。
  3. 経口投与剤であることを特徴とする請求項１または２記載の変形関節症治療剤。
JP2005163086A 2005-06-02 2005-06-02 変形性関節症の治療剤 Active JP4041856B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005163086A JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005163086A JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007192197A Division JP2007262103A (ja) 2007-07-24 2007-07-24 変形性関節症の治療剤

Publications (3)

Publication Number Publication Date
JP2006335694A JP2006335694A (ja) 2006-12-14
JP2006335694A5 true JP2006335694A5 (ja) 2007-09-06
JP4041856B2 JP4041856B2 (ja) 2008-02-06

Family

ID=37556549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005163086A Active JP4041856B2 (ja) 2005-06-02 2005-06-02 変形性関節症の治療剤

Country Status (1)

Country Link
JP (1) JP4041856B2 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0621470A2 (pt) 2006-12-05 2011-12-13 Glycoscience Lab Inc agente terapêutico para artrite degenerativa
SG11201404959TA (en) * 2012-02-22 2014-11-27 Hyaluronan Res Inst Inc Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent

Similar Documents

Publication Publication Date Title
JP2010522242A5 (ja)
EP2444072A3 (en) Non-mucoadhesive film dosage forms
JP2009541479A5 (ja)
JP2006502129A (ja) 腎臓濾過および腎臓通過中のリソソーム分解に対して耐性を示す抗微生物性荷電ポリマー、その組成物および使用方法
CL2007002347A1 (es) Compuestos derivados de fenilo, piridina y quinolina; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de diabetes mellitus, trastornos en la tolerancia de la glucosa, obesidad, enfermedad de crohn, enferm
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
JP2009532087A5 (ja)
NO20084919L (no) Oksadiazolidindionforbindelse
NO20083562L (no) Cannabinoidreseptormodulatorer
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
JP2009542581A5 (ja)
JP2008531647A5 (ja)
EP2455085A3 (en) Use of at least one compound of the family of the avermectins or of the family of the milbemycins in the treatment of ophthalmic pathologies
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
JP2009537554A5 (ja)
WO2008090631A1 (ja) フコイダン由来オリゴ糖
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
JP2005507891A5 (ja)
NO20070146L (no) 4-fenylpyrimidin-2-karbonitril-derivater
JP2007126453A5 (ja)
WO2009041111A1 (ja) 経口投与剤
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
JP2006342148A5 (ja)
WO2007070355A3 (en) Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes